Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
The development of an effective vaccine is a powerful tool to contain the global spread of coronavirus disease 2019 (COVID-19). Still, it raises potential safety concerns about the subsequent enhancement of as...
Source: BMC Endocrine Disorders - Category: Endocrinology Authors: Avraham Ishay and Elena Chertok Shacham Tags: Case report Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | Diabetes | Diabetes Insipidus | Endocrinology | SARS | Vaccines